Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-19T12:21:08.911Z Has data issue: false hasContentIssue false

Cytochemical Localization of Adenylate Cyclase in Broken Cell Preparations of the Cerebral Cortex

Published online by Cambridge University Press:  18 September 2015

S. W. French*
Affiliation:
Departments of Pathology, University of British Columbia, Canada and the University of California School of Medicine, Davis, California, and the Veterans Administration Hospital, Martinez, California
D. S. Palmer
Affiliation:
Departments of Pathology, University of British Columbia, Canada and the University of California School of Medicine, Davis, California, and the Veterans Administration Hospital, Martinez, California
M. Caldwell
Affiliation:
Departments of Pathology, University of British Columbia, Canada and the University of California School of Medicine, Davis, California, and the Veterans Administration Hospital, Martinez, California
*
Veterans Administration Hospital, 150 Muir Road, Martinez, Ca. 94553, U.S.A.
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Broken cell preparations derived from rat cerebral cortical grey matter were studied cytochemically to localize adenylate cyclase (AC) activity in subcellular organelle membranes. AC activity was localized by visualizing reaction product in brain particulate fractions by electron microscopy. Activity was found in the endoplasmic reticulum, on the inside of the inner mitochondrial membrane and on both leaflets of the nuclear membrane. Reaction product was found in the postsynaptic density area of most synapses. The reaction product tended to be more prominent in the presence of flouride. A synaptosome-rich fraction was shown to have NE stimulated AC activity which was blocked in vitro by both a α-and an β-blocker and in vivo by propranolol.

Type
Research Article
Copyright
Copyright © Canadian Neurological Sciences Federation 1978

References

Borle, A.B. (1974). Cyclic AMP stimulation of calcium efflux from kidney, liver and heart mitochondria. Journal of Membrane Biology 16, 221236.CrossRefGoogle ScholarPubMed
Byus, C.V., and Russell, D.H. (1975). Ornithine decarboxylase activity: control by cyclic nucleotides. Science 187, 650652.CrossRefGoogle ScholarPubMed
Cheng, H. and Farquhar, M.G. (1976). Presence of adenylate cyclase activity in Golgi and other fractions from rat liver. I Biochemical determinations, II Cytochemical localization within Golgi and ER membranes. Jouranl of Cell Biology 70: 660670 and 671684.Google Scholar
Cuatrecasas, P., Tell, G.P.E., Sica, V., Parikh, I., and Chang, K.J. (1974). Noradrenaline binding and the search for catecholamine receptors. Nature 247, 9297.CrossRefGoogle ScholarPubMed
Cutler, L.S. (1975). Comments on the validity of the use of lead nitrate for the cytochemical study of adenylate cyclase. Journal of Histochemistry and cytochemistry 23: 786787.CrossRefGoogle ScholarPubMed
De Belleroche, J.S. Das, I., and Bradford, H.F. (1974). Absence of an effect of histamine, noradrenaline and depolarizing agents on the level of adenosine 3,5 -monophosphate in nerve endings isolated from cerebral cortex. Biochemical Pharmacology 23, 835843.Google Scholar
Drummond, G.I. and Duncan, L. (1970). Adenylcyclase in cardiac tissue. Journal of Biological Chemistry 245, 976983.CrossRefGoogle ScholarPubMed
Drummond, G.I. and Ma, Y. (1973). Metabolism and functions of cyclic AMP in nerve. Progress in Neurobiology 2: 119176.CrossRefGoogle ScholarPubMed
Florendo, N.I., Barrnett, R.J. and Greengard, P. (1971). Cyclic 3’, 5’-nucleotide phosphodiesterase: Cytochemical localization in cerebral cortex. Science 173, 745747.Google Scholar
French, S.W., Ihrig, T.J., and Norum, M.L. (1972). A method of isolation of Mallory bodies in a purified fraction. Laboratory Investigation 26, 240244.Google Scholar
French, S.W., and Palmer, D.S. (1973). Adrenergic supersensitivity during ethanol withdrawal in the rat. Research Communications of Chemical Pathology and Pharmacology 6, 651662.Google ScholarPubMed
French, S.W. Palmer, D.S. and Narod, M.E., (1976). Noradrenergic subsensitivity of rat liver homogenates during chronic ethanol ingestion. Research Communications in Chemical Pathology and Pharmacology, 13: 283295.Google ScholarPubMed
Gilman, A.G. (1970). A protein binding assay for adenosine 3’, 5’-cyclic monophosphate. Proceedings of the National Academy of Science, USA 67, 305312.Google Scholar
Hayes, A., and Cooper, R.G. (1971). Studies on the absorption, distribution and excretion of propranolol in rat. dog and monkey. Journal of Pharmacology and Experimental Therapeutics 176: 302311.Google Scholar
Howell, S.L., and Whitfield, M. (1972). Cytochemical localization of adenyl cyclase activity in rat islets of Langerhans. Journal of Histochemistry and Cytochemistry, 20: 873879.Google Scholar
Joó, R. and Tóth, I. (1975). Brain adenylate cyclase: Its common occurrence in the capillaries and astrocytes. Naturwissen-schaften 8: 397.Google Scholar
Katz, A.M., Michihiko, T., Repke, D.I., Iorio, J.A.M. and Kirchberger, M.A. (1974). Adenylate cyclase: Its probably localization in sarcoplasmic reticulum as well as sarcolemma of the canine heart. Journal of Molecular and Cellular Cardiology, 6: 7378.CrossRefGoogle Scholar
Kleitke, B., Sydow, H. and Wol-Lenberger, A. (1976). Evidence for cyclic AMP-dependent protein kinase activity in isolated guinea pig and rat liver mitochondria. Acta Biol. Med. Germ., 35: 917.Google Scholar
Kebabian, J.W., Bloom, F.E., Steiner, A.L. and Greengard, P. (1975). Neurotransmitters increase cyclic nucleotides in postganglionic neurons: Immunocytochemical demonstration. Science 190: 157159.Google Scholar
Lemay, A. and Jarett, L. (1975). Pitfalls in the use of lead nitrate for the histochemical demonstration of adenylate cyclase activity. Journal of Cell Biology 65: 3950.Google Scholar
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193: 265275.CrossRefGoogle ScholarPubMed
McAfee, D.A., Schorderet, M., and Greengard, P. (1971). Adenosine 3’, 5’-monophosphate in nervous tissue: Increase associated with synaptic transmis-sion. Science, 171: 11561158.CrossRefGoogle Scholar
McAfee, D.A. and Greengard, P. (1972). Adenosine 3’, 5’-monophosphate: Electrophysiological evidence for a role in synaptic transmission. Science 178: 310312.Google Scholar
McKeel, D.W. and Jarett, L. (1974). The enrichment of adenylate cyclase in the plasma membrane and Golgi subcellular fractions of porcine adenohypothesis. Journal of Cell Biology, 62: 231236.Google Scholar
Melnick, R.L. De Sousa, J.T., Maguire, J., and Packer, L. (1975). Action of the adenosine triphosphate analog, adenylyl imidodiphosphate in mitochondrial ATPase. Archives of Biochemistry and Biophysics 166: 139144.CrossRefGoogle Scholar
Navarro, G., Richardson, R., and Zuban, A.T. (1976). Propranolol and morphine. Psychopharmacology 51: 3942.Google Scholar
Orzack, M.H., Branconnier, R., and Gardos, G. (1973). CNS effects of propranolol in man. Psychopharmacologia 29: 299306.Google Scholar
Penefsky, H.S. (1974). Differential effects of adenylyl imidodiphosphate on adenosine triphosphate synthesis and the partial reactions of oxidative phosphorylation. Journal of Biological Chemistry. 249: 35793585.CrossRefGoogle ScholarPubMed
Rechardt, L., and HäRkönen, M. (1977). Electron microscopical demonstration of adenylate cyclase activity in nervous tissue. Histochemistry 51: 113119.CrossRefGoogle ScholarPubMed
Rechardt, L., and Härkönen, M. (Personal Communications).Google Scholar
Robison, G.A., Schmidt, M.J. and Sutherland, E.W. (1970). On the development and properties of the brain adenyl cyclase system. Advances in Biochemistry and Psychopharmacology. 3: 1130.Google ScholarPubMed
Sato, T., Garcia-Bunuel, R., and Brandes, D. (1974). Ultrastructural cytochemical localization of adenylate cyclase in the rat nephron. Laboratory Investigation 30: 222229.Google Scholar
Schulze, W., Krause, E.G. and Wollenberger, A. (1972). Cytochemical demonstration and localization of adenyl cyclase in skeletal and cardiac muscle. Advances in Cyclic Nucleotide Research 1: 249259.Google Scholar
Sulimovici, S., and Lunenfeld, B. (1974). Effect of gonadotrophins on adenylate cyclase of outer and inner membrane subfractions of rat testis mitochondria. Febs. Letters. 41: 345347.CrossRefGoogle ScholarPubMed
Sulimovici, S., Bartoov, B. and Lunenfeld, B. (1975). Rat testis mitochondrial adenylate cyclase partial purification and characterization. Biochemica et Biophysica Acta 377: 454462.Google Scholar
Trams, E.G., and Lauter, C.J. (1974). On the sidedness of plasma membrane enzymes. Biochimica et Biophysica Acta. 345: 180197.Google Scholar
Tu, J.C. and Malhotra, S.K. (1973). Histochemical I localization of adenyl cyclase in the fungus Phycomyces blakes-leeanus. Journal of Histochemistry and Cytochemistry. 21: 10411046.CrossRefGoogle Scholar
Ueda, T., Maino, H., and Greengard, P. (1973). Regulation of endogenous phosphorylation of specific proteins in synaptic membrane fractions from rat brain by Adenosine 3’, 5’-monophosphate. Journal of Biological Chemistry, 248: 8295, 8305.CrossRefGoogle ScholarPubMed
Venter, J.C. and Kaplan, N.O. (1974). Stability of catecholamines immobilized on glass beads. Science 185: 459460.CrossRefGoogle ScholarPubMed
Von Hungen, K., and Roberts, S. (1973). Adenylate-cyclase receptors for ad-renergic neurotransmitters in rat cerebral cortex. European Journal of Biochemistry, 36: 391401.Google Scholar
Wedner, H.J., Hoffer, B.J., Bloom, F.E. and Parker, C.W. (1973). Catecholamine stimulation of cyclic AMP in the nucleus of human peripheral lympho-cytes. Federation Proceedings, 32, 744 (abstr.)Google Scholar
Yong, M.S., and Richardson, J.B. (1974). Stability of catecholamines immobilized on glass beads. Science 185: 460461.Google Scholar
Yorkston, N.J., Zaki, S.A., Malik, M.K.U., Morrison, R.C. and Havard, C.W.H. (1974). Propranolol in the control of schizophrenic symptoms. British Medical Journal, pp 633635.Google Scholar